Author Archives: sobalas

Celebrating National Women Physicians Day

By: Jon Stallkamp, MD, Interim Chief Medical Officer   This week, we celebrated National Women Physicians Day. This day falls every year on February 3, the birthday of Elizabeth Blackwell, the first woman to practice medicine in the US.   … Continue reading

Posted in Uncategorized | Leave a comment

Clinical Trial of the Week: Device trial to treat mitral valve regurgitation

By Donna Loyle, communications manager, LIMR   The new Repair MR randomized controlled trial seeks to compare the clinical outcome of the MitraClip™ device vs. surgical repair in patients with severe primary mitral regurgitation who are at moderate surgical risk … Continue reading

Posted in Uncategorized | Leave a comment

Vaccine Update from Dr. Jon Stallkamp

Sent on behalf of Jon Stallkamp, MD…   To our Main Line Health physician partners:   Since the state’s expanded criteria for COVID vaccination eligibility was announced last week, I know that your offices and our call centers have dealt with … Continue reading

Posted in Uncategorized | Leave a comment

Welcome Pam Teufel to Main Line Health

Sent on behalf of Jack Lynch…   Colleagues,   Following Paul Yakulis’ retirement in September 2020, Main Line Health began an extensive nationwide search for his successor. I am pleased to announce that Pam Teufel will join the team in … Continue reading

Posted in Uncategorized | Leave a comment

Clinical Trial of the Week: Treatment study for older patients with advanced non-small lung cancer

By Donna Loyle, communications manager, LIMR   Researchers seek to determine if there are any side effects of Keytruda® (pembrolizumab) with or without chemotherapy in treating patients aged 70 and older diagnosed with metastatic, stage 4 non-small cell lung cancer. … Continue reading

Posted in Uncategorized | Leave a comment

Latest Clinical Research from LIMR

By Donna Loyle, communications manager, LIMR   Research studies with clinical implications for patients with COVID-19, triple negative breast cancer, aortic valve replacement, atrial fibrillation, lung cancer and chronic cough were published in peer-reviewed journals by investigators at the Lankenau … Continue reading

Posted in Uncategorized | Leave a comment

Clinical Trial of the Week: Phase II treatment study for breast cancer

By Donna Loyle, communications manager, LIMR   In this randomized phase II clinical trial, researchers are studying how well docetaxel or paclitaxel work in reducing chemotherapy-induced peripheral neuropathy in a patient cohort comprised of African American women diagnosed with stages … Continue reading

Posted in Uncategorized | Leave a comment

Serious drug-induced cardiac side effect accurately detected and scored by LIMR researcher

By Donna Loyle, communications manager, LIMR   A new study coauthored by investigators at the Lankenau Institute for Medical Research (LIMR) showed the utility of a scoring system enabled by a LIMR-developed assay in predicting drug-induced torsade de pointes (TdP). … Continue reading

Posted in Uncategorized | Leave a comment

Hepatitis C laboratory test process change

Effective Dec 21st we have started Hepatitis C antibody testing with reflex to Hep C by RNA for both employees and source patients for needle stick/other exposures. This is to comply with new CDC recommendation (July 2020) for reflex testing … Continue reading

Posted in Uncategorized | Leave a comment

Clinical Trial of the Week: Diagnostic device trial for patients with metastatic breast cancer

By Donna Loyle, communications manager, LIMR   Researchers, including those at MLH, seek to evaluate the performance of fludeoxyglucose F-18 (FDG)-PET/CT response criteria as a binary predictor of progression-free survival in patients with bone-dominant metastatic breast cancer treated with systemic … Continue reading

Posted in Uncategorized | Leave a comment